Quick Answer
Hepion Pharmaceuticals, Inc. reported Common Stock Shares Outstanding of 11.62 million shares for the year ending 2025.
- Hepion Pharmaceuticals, Inc. showed an increase of +8,249.8% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Hepion Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q3 2013: 9.00 million shares | Q4 2013: 9.00 million shares | Q1 2014: 9.00 million shares | Q3 2014: 22.24 million shares | Q4 2014: 22.27 million shares | Q1 2015: 22.27 million shares | Q3 2015: 22.30 million shares | Q4 2015: 27.30 million shares | Q1 2016: 27.30 million shares | Q3 2016: 55.59 million shares | Q4 2016: 62.78 million shares | Q1 2017: 63.71 million shares | Q2 2017: 75.71 million shares | Q3 2017: 78.17 million shares | Q1 2018: 84.95 million shares | Q2 2018: 10.69 million shares | Q3 2018: 16.32 million shares | Q1 2019: 20.79 million shares | Q2 2019: 3.45 million shares | Q3 2019: 3.45 million shares | Q1 2020: 6.07 million shares | Q2 2020: 9.03 million shares | Q3 2020: 9.03 million shares | Q1 2021: 76.23 million shares | Q2 2021: 76.23 million shares | Q3 2021: 76.23 million shares | Q1 2022: 76.23 million shares | Q2 2022: 76.23 million shares | Q3 2022: 76.23 million shares | Q1 2023: 3.81 million shares | Q2 2023: 3.84 million shares | Q3 2023: 3.84 million shares | Q1 2024: 5.47 million shares | Q2 2024: 5.80 million shares | Q3 2024: 6.96 million shares | Q1 2025: 9.59 million shares | Q2 2025: 11.62 million shares | Q3 2025: 11.62 million shares.
- Over the full 15 years of available data (2012 to 2025), Hepion Pharmaceuticals, Inc.'s Common Stock Shares Outstanding has grown by 29.1%.
- Historical annual values: Fiscal year 2025: 11.62 million shares | Fiscal year 2024: 139,168 shares | Fiscal year 2023: 96,375 shares | Fiscal year 2022: 3.81 million shares | Fiscal year 2021: 76.23 million shares | Fiscal year 2020: 32.03 million shares | Fiscal year 2019: 3.76 million shares | Fiscal year 2018: 247,013 shares | Fiscal year 2017: 9.79 million shares | Fiscal year 2017: 75.71 million shares | Fiscal year 2016: 32.23 million shares | Fiscal year 2015: 22.28 million shares | Fiscal year 2014: 18.48 million shares | Fiscal year 2013: 9.00 million shares | Fiscal year 2012: 9.00 million shares.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: